HUTCHMED to Announce 2025 Half-Year Financial Results
July 03, 2025 04:30 ET | Source: HUTCHMED (China) Limited HONG KONG…
Cellectar Biosciences Announces One-for-Thirty Reverse Stock Split
June 18, 2025 16:30 ET | Source: Cellectar Biosciences, Inc. FLORHAM PARK,…
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…
Celularity Receives Nasdaq Notice Regarding Form 10-Q
May 30, 2025 17:30 ET | Source: Celularity Inc. FLORHAM PARK, N.J.,…